EVOQ is pioneering the development of cancer vaccine nanodiscs that evoke an immune response 30 times more powerful than other cancer vaccines and was selected as the top winner at the 10th annual Accelerate Michigan Innovation Competition (AMIC), a pitch competition that provides critical funding and support for Michigan startups. The company was chosen from 24 semi-finalists as the winner of the $350,000 grand prize.